BATON ROUGE, La. (AP) — In a pivotal moment that underscored how powerful and immersive social platforms can be for children and teens, a jury in California this week found both Meta and YouTube ...

Add Futurism (opens in a new tab) Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. For quite some time now, ...

Palantir CEO Alex Karp confirmed that Anthropic's Claude is still being used in the company's tools despite the startup's blackisting by the Pentagon. The Defense Department designated Anthropic a ...

Birmingham-based contractor Brasfield & Gorrie is planning a $64.5 million expansion of its Magic City headquarters, in a move the company says will create 80 new jobs. Officials with the company ...

[Maximilian Milovidov is a freshman at Columbia University and a member of TikTok's Youth Council. He used a large language model to edit this essay for length and a human to edit for content. This ...

Tens of thousands of shoppers are reporting widespread problems using Amazon’s website, according to reports from outage tracker Downdetector. As of 3:45 p.m. ET on Thursday, March 5, reports of ...

A growing number of Pennsylvania hospitals are creating private police forces to combat rising violence against healthcare workers. While supporters say on-site police improve safety, some experts ...

Cybersecurity researchers have flagged malicious Packagist PHP packages masquerading as Laravel utilities that act as a conduit for a cross-platform remote access trojan (RAT) that's functional on ...

Washington — President Trump announced Friday that he is ordering all federal agencies to "immediately" stop using Anthropic's artificial intelligence technology, as the company neared a Pentagon ...

SAN FRANCISCO, CA - Crypto isn’t just building faster payments rails. It may be building the financial system for non-humans. As AI agents grow more autonomous, developers are already giving them ...

Merck said on Monday it would split its business into two, creating ⁠a distinct division for its cancer franchise led by blockbuster drug Keytruda while grouping its non-oncology treatments separately ...